Howard Maibach, MD

Patch testing with 2.0% (0.60 mg/cm 2) formaldehyde instead of 1.0% (0.30 mg/cm 2) detects significantly more contact allergy.

Pontén A, Aalto-Korte K, Agner T, Andersen KE, Giménez-Arnau AM, Gonçalo M, Goossens A, Johansen JD, Le Coz CJ, Maibach HI, Rustemeyer T, White IR, Bruze M PMID: 23035891

Sensitive skin: an overview.

Berardesca E, Farage M, Maibach H PMID: 22928591

Localized scleroderma variants: pharmacologic implications.

Jackson CT, Maibach HI PMID: 22905721

Anti-irritants agents for the treatment of irritant contact dermatitis: clinical and patent perspective.

Zhai H, Maibach HI PMID: 22827755

Randomized, vehicle-controlled trials of topical 5-fluorouracil therapy for actinic keratosis treatment: an overview.

Rahvar M, Rhavar M, Lamel SA, Maibach HI PMID: 23046237

The clinical significance of immunological contact urticaria to processed grains.

Ismail M, Maibach HI PMID: 22960814

Interindividual variation in transdermal and oral drug deliveries.

Levin J, Maibach H PMID: 22927031

Onychopharmacokinetics of terbinafine hydrochloride penetration from a novel topical formulation into the human nail in vitro.

Hui X, Lindahl Å, Lamel S, Maibach HI PMID: 22873754

Dermal exposure to methamphetamine hydrochloride contaminated residential surfaces: surface pH values, volatility, and in vitro human skin.

Salocks CB, Hui X, Lamel S, Qiao P, Sanborn JR, Maibach HI PMID: 22902806

Percutaneous absorption in diseased skin: an overview.

Chiang A, Tudela E, Maibach HI PMID: 22912973